Trials / Recruiting
RecruitingNCT07141277
GRANITE: Airsupra Effectiveness in the Real World
GRANITE: Airsupra Effectiveness in the Real World A Retrospective Prevalent New-user Cohort Study to Describe Characteristics and Compare Effectiveness of Airsupra vs Albuterol, in Patients With Asthma Requiring Use of Rescue Therapy in a Real-world Setting in the United States
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None (Observational study) | Not applicable since it's an observational study. |
Timeline
- Start date
- 2025-07-09
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2025-08-26
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07141277. Inclusion in this directory is not an endorsement.